-
Progress in Cancer Care: What the Numbers Tell Us About Lung Cancer
Every January, the American Cancer Society releases a Cancer Facts & Figures report. It provides a clear view of where we stand in addressing cancer. The 2026 report brings both encouraging news and a...
IN THE SPOTLIGHT
-
Artificial Intelligence in Lung Cancer: Hope vs. Hype
Artificial intelligence (AI) is rapidly reshaping the future of cancer care, but such dramatic innovation also brings important questions. AI has evolved from early consumer tools... -
Small Cell SMASHERS Fireside Chat with Dr. Eric Singhi
Eric Singhi, MD, assistant professor, University of Texas MD Anderson Cancer Center, joined us to discuss the role of community and support in people with small cell lung cancer... -
Explaining BiTE® Therapy
A bi-specific T-cell engager (BiTE®) is a new type of engineered molecule used for the treatment of cancer. These molecules harness and activate T-cells, which are involved in the... -
Why Immunotherapy Isn’t Perfect & How Scientists Are Working to Fix It
The human immune system is an intricate web of checks and balances that usually excels at detecting and destroying foreign invaders, such as bacteria and viruses, while protecting... -
SCLC Virtual Meetup
SCLC patients/survivors - Join us the 3rd Wednesday of every month to c onnect with others who share common experiences and build your community. Register in advance for this... -
Small Cell SMASHERS Fireside Chat with Dr. Misty Shields
This special edition of the Small Cell SMASHERS features Misty Shields, MD, PhD, as a guest instead of her usual role as host. Dr. Shields is a thoracic medical oncologist... -
Small Cell SMASHERS Fireside Chat: Who's Up Next?
Small Cell SMASHERS Fireside Chat with Dr. Laura Alder Join us for a YouTube Live on Friday, March 20, with Laura Alder, MD, Assistant Professor of Medicine in the Division of... -
Biggest News from Berlin: Research Highlights from ESMO
Lung cancer research was in the spotlight at the European Society for Medical Oncology (ESMO) meeting held October 17-21, 2025, in Berlin, Germany. With approximately 30,000... -
The Future of Lung Cancer Starts Here
For more than two decades, LUNGevity Foundation has been a leader in advancing lung cancer research. Since 2002, we have invested $55+ million in more than 200 research projects...
When Small Cell Lung Cancer Hides from Immune Cells, Blood Vessels May Hold the Key
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer
Immunotherapy rechallenge in Extensive-Stage small cell lung Cancer: A Real-World retrospective study
Immunotherapy rechallenge in Extensive-Stage small cell lung Cancer: A Real-World retrospective study
Immunotherapy rechallenge in Extensive-Stage small cell lung Cancer: A Real-World retrospective study
Immunotherapy rechallenge in Extensive-Stage small cell lung Cancer: A Real-World retrospective study
How to Talk to Your Oncologist About LEMS
Quizzes
Reviewing the IMforte Phase 3 Data in Extensive Stage Small Cell Lung Cancer
WHEN SMALL CELL LUNG CANCER HIDES FROM IMMUNE CELLS, BLOOD VESSELS MAY HOLD THE KEY
Small Cell Lung Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 100+ Key Companies | DelveInsight
Small Cell Lung Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 100+ Key Companies | DelveInsight